A frequent New York Times commenter on important ovarian cancer issues, OCRF wrote a Letter to the Editor in response to the NYT editorial, “Inadequate Treatment of Ovarian Cancer,” which was published in print and online on March 21, 2013. We are grateful for the opportunity to reach such a large audience regarding the importance of seeking opinions and treatments from a gynecologic oncologist in the face of an ovarian cancer diagnosis.
Related Topics
Global Research Push Resonates Across Airwaves
News of the newly launched Global Ovarian Cancer Research Consortium — and its inaugural AI Accelerator Grant — is spreading quickly, with media outlets across the country taking notice. The … Continued
New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates
Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research … Continued
OCRA’s Health Equity Research Grant Recipients
In the newest installment of our continuing introduction of our 2025 grantees, Ovarian Cancer Research Alliance (OCRA) is proud to highlight the three recipients of our 2025 Health Equity Research Grants, … Continued